Lithium
Active pharmaceutical substance formulated in Jan Aushadhi generic products for CNS, Nerve & Mental Health treatment.
🧴 Clinical Application
Swallow prolonged-release tablets whole with a full glass of water, with or after meals to minimize nausea. Do not crush or chew. Maintain consistent daily fluid and dietary sodium intake; dehydration or salt restriction causes toxic lithium accumulation.
⚠️ Side Effects
Common: Fine hand tremor, polyuria, polydipsia, mild nausea, diarrhea, weight gain, metallic taste, fatigue. Rare/Severe: Boxed warning: Lithium toxicity (serum level >= 1.5 mEq/L: coarse tremor, ataxia, confusion, convulsions, coma, irreversible neurotoxicity); nephrogenic diabetes insipidus, hypothyroidism, and goiter.
🛡️ Safety Warnings
Black box warning: Lithium toxicity is closely related to serum concentrations and can occur at doses close to therapeutic levels (target: 0.6-1.2 mEq/L). Regular serum lithium, renal function, electrolytes, and thyroid monitoring are mandatory. Contraindicated in severe renal disease and severe dehydration. Avoid concurrent NSAIDs, ACE inhibitors, and thiazide diuretics which elevate lithium levels.
Jan Aushadhi Products containing Lithium
Found 2 generic formulation(s) containing this active ingredient.
Lithium Carbonate Prolonged Release Tablets 450mg
Lithium Carbonate is the classical mood-stabilizing monovalent cation on the WHO Model List of Essential Medicines. It alters neuronal sodium transport, inhibits inositol monophosphatase (depleting free intracellular inositol and dampening phosphoinositide signaling), and inhibits glycogen synthase kinase-3 beta (GSK-3beta), providing neuroprotective neuroplasticity. Indicated for the treatment of acute manic and mixed episodes in bipolar disorder and long-term maintenance therapy to prevent bipolar relapses and decrease suicide risk.
Lithium Carbonate Tablets 300mg
Lithium Carbonate is the classical mood-stabilizing monovalent cation on the WHO Model List of Essential Medicines. It alters neuronal sodium transport, inhibits inositol monophosphatase (depleting free intracellular inositol and dampening phosphoinositide signaling), and inhibits glycogen synthase kinase-3 beta (GSK-3beta), providing neuroprotective neuroplasticity. Indicated for the treatment of acute manic and mixed episodes in bipolar disorder and long-term maintenance therapy to prevent bipolar relapses and decrease suicide risk.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Lithium.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Lithium Carbonate Prolonged Release Tablets 450mg | 10's | ₹18.75 | Lithic, Manicarb | ₹47.99 | 61% Save |
| Lithium Carbonate Tablets 300mg | 10's | Under Process | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Lithium generics.